Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1998
06/03/1998CN1183767A Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
06/03/1998CN1183724A Laryngeal bactericidal and antiseptic composition
06/03/1998CN1183722A Use of penciclovir for treatment of human herpes-virus-8
06/03/1998CN1183298A Capsule for treatment of AIDS and preparing method thereof
06/03/1998CN1038592C 2', 5' -oligoadenylate derivs. and pharmeceutical composition contg. same
06/03/1998CN1038591C Processes for diastereoselective synthesis of nucleosides
06/03/1998CN1038589C Process for preparing 7 -acyl -3 -(substd. carbamyloxy) cephen compound
06/03/1998CN1038588C Process for preparing 4 £4 -£4 -£4 -££2 -(2, 4 -difluorophenyl) -2 -(1H -azolylmethyl) -1, 3 -dioxlan -4 -yl| methox| phenyl| -1 -piperazinyl| phenyl| triazolones
06/03/1998CN1038559C Method for preparing vaccine against E coli septicaemia in poultry
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760245 Homochiral intermediates for preparation of orally active azole derivatives
06/02/1998US5760233 Chemical intermediates for making erythromycins antibiotics
06/02/1998US5760185 Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760175 Peptide to detect several herpes virus infections
06/02/1998US5760064 Sulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitors
06/02/1998US5760036 Enzyme inhibitors of retroviral protease for prevention of aids
06/02/1998US5760026 Administering lysostaphin
06/02/1998US5760011 Antibiotic macrolides
06/02/1998US5759995 Administering cyclomarin a to treat herpes virus infections
06/02/1998US5759813 Methods and compositions relating to useful antigens of moraxella catarrhalis
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759770 Retrovirus from the HIV group and its use
06/02/1998US5759769 Diagnostic kits, vaccines; immobilized peptide having amino acid sequence epitope
06/02/1998US5759584 Method for treating skin afflicted with blemishes or acne with a composition comprising distilled wool wax acids and at least one monoglycerol monocarboxylic acid monoester
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
06/02/1998CA1339896C Dideoxydidehydrocarbocyclic nucleosides
05/1998
05/28/1998WO1998022610A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998WO1998022575A2 Nucleotide sequence of escherichia coli pathogenicity islands
05/28/1998WO1998022498A1 Cyclic hexapeptides having antibiotic activity
05/28/1998WO1998022496A2 Antiviral peptide derivatives
05/28/1998WO1998022490A1 DIRECT METHODS FOR MOLAR-MASS DETERMINATION OF FRAGMENTS OF HAEMOPHILUS INFLUENZAE TYPE b CAPSULAR POLYSACCHARIDES AND VACCINE PREPARATION
05/28/1998WO1998022487A1 Combinatorial synthesis of carbohydrate libraries
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022438A1 Cyclic imines as pesticides
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998022145A1 Immunization of infants
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022121A1 Reductive alkylation of glycopeptide antibiotics
05/28/1998WO1998022111A1 Anti-helicobacter pylori drugs
05/28/1998WO1998022106A1 Pharmaceutical composition
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998DE19648011A1 Cyclische Imine Cyclic imines
05/28/1998CA2272047A1 Nucleotide sequence of escherichia coli pathogenicity islands
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2271288A1 Antiviral peptide derivatives
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998CA2267833A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998CA2256694A1 Combinatorial synthesis of carbohydrate libraries
05/27/1998EP0844307A1 Candida albicans protein caYAE1
05/27/1998EP0843818A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
05/27/1998EP0843680A1 Process for the preparation of potassium clavulanate
05/27/1998EP0843663A1 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
05/27/1998EP0843565A1 Coarse spray delivery of functional biologic materials
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998EP0843556A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
05/27/1998EP0843552A2 Pharmaceutical formulations
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0666861B1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
05/27/1998EP0646125B1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
05/27/1998EP0618800B1 Glycosylated steroid derivatives for transport across biological membranes and process for making same
05/27/1998CN1183102A Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/27/1998CN1183048A Oral pharmaceutical dosage forms comprising a proton pump inhibitor and nsaid
05/27/1998CN1182739A N-benzylazolium derivatives
05/27/1998CN1182619A External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof
05/27/1998CN1182616A Medicine for curing viral hepatitis
05/27/1998CN1182611A Traditional Chinese powder medicine for hepatosis
05/27/1998CN1182601A Keyoulin sterilizing bactericide
05/27/1998CN1038509C Process for preparing 8-chloroquinolone derivatives
05/26/1998US5756765 2- (2-Substituted pyrrolidin-4-yl) thio-carbapenem derivatives
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756732 Substituted heteroarylphenyloxazolidinones
05/26/1998US5756723 Metal-mediated cross-coupling with ring-metalated porphyrins
05/26/1998US5756718 Anti-endotoxin compounds
05/26/1998US5756711 Viricides
05/26/1998US5756706 Chemical intermediates
05/26/1998US5756674 Fusion proteins
05/26/1998US5756669 Mutants
05/26/1998US5756668 Hypermethylated in cancer polypeptide, HIC-1
05/26/1998US5756534 Retroviral protease inhibitors
05/26/1998US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/26/1998US5756524 Applying to combat cytopathogenic fungi
05/26/1998US5756505 N-acylpiperazine derivative, antibacterial drug and anti-ulcer drug
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756494 Protein kinase inhibitors for treatment of neurological disorders
05/26/1998US5756491 Antiviral cobalt-organic compounds
05/26/1998US5756486 Cyclized nucleotide; viricide
05/26/1998US5756485 Silicone-containing derivatives of salicylic acid which have desquamating properties
05/26/1998US5756481 Cysteine
05/26/1998US5756477 Treatment of aids with complex of poly (A). poly (U)
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756312 Dna molecule encoding polypeptide comprising two heterogeneous amino acid sequences from same variable domain of hepatitis c virus isolates
05/26/1998US5756284 Self-assembling recombinant papillomavirus capsid proteins
05/26/1998US5756121 Forming liposomes for treatment of drug resistant bacteria
05/26/1998US5756103 Alvac canarypox virus recombinants comprising heterlogous inserts
1 ... 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 ... 1798